or Try an Advanced Search...

    Technical Analysis for KPRX - Kiora Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.49 -2.53% -0.01
    KPRX closed down 3.84 percent on Tuesday, May 7, 2024, on 52 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical KPRX trend table...
    Date Alert Name Type % Chg
    Earnings Movers Other -2.53%
    Inside Day Range Contraction -2.53%
    20 DMA Resistance Bearish -6.28%
    Pocket Pivot Bullish Swing Setup -6.28%
    Wide Bands Range Expansion -6.28%
    Gapped Down Weakness -6.28%
    Fell Below 20 DMA Bearish -4.87%
    Wide Bands Range Expansion -4.87%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -10.01%
    20 DMA Support Bullish -10.01%
    Older End-of-Day Signals for KPRX ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 1 hour ago
    Up 3% about 1 hour ago
    Up 2% about 1 hour ago
    Up 1% about 1 hour ago
    Down 3% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    KPRX Chart by TradingView
    Basic chart:

    Profile

    Kiora Pharmaceuticals, Inc. Description

    EyeGate Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. EyeGate's lead product, Ocular Bandage Gel ('OBG'), is based on a modified form of the natural polymer hyaluronic acid. The objective of OBG is to protect the ocular surface in order for the body to re-epithelialize the cornea and improve ocular surface integrity. The product is applied as a clear topical gel, to the damaged ocular surface, and possesses unique properties that help hydrate and protect the ocular surface to allow for wound healing. EyeGate is in clinical evaluation for two different patient populations: (1) patients undergoing photorefractive keratectomy ('PRK') surgery to demonstrate corneal wound repair after refractive surgery; and (2) patients with punctate epitheliopathies ('PE') as a result of dry eye to promote reduction of PEs.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Pharmaceutical Disease Surgery Disorders Eye Surgery Hyaluronic Acid Lasik Refractive Surgery

    Is KPRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Kiora Pharmaceuticals to Present at The Citizens JMP Life Sciences Conference
    May 6 Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa
    Apr 11 Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
    Apr 5 Kiora Pharmaceuticals to Present at Upcoming Investor Conferences
    Mar 28 Kiora Pharmaceuticals to Present Additional Data from Its ABACUS-1 Trial in Retinitis Pigmentosa at the ARVO 2024 Annual Meeting
    Mar 25 Kiora Pharmaceuticals reports FY results
    Mar 25 Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases
    Mar 8 Kiora Announces Publication of Phase 1 Study Demonstrating Safety, Tolerability and Anti-Inflammatory Activity of KIO-101 in the Treatment of Inflammation of the Eye
    Feb 28 Kiora Pharmaceuticals files to sell 76.53M shares of common stock for holders
    Feb 2 Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
    See more KPRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.6417
    52 Week Low 0.4511
    Average Volume 217,945
    200-Day Moving Average 0.58
    50-Day Moving Average 0.59
    20-Day Moving Average 0.53
    10-Day Moving Average 0.51
    Average True Range 0.05
    RSI (14) 43.82
    ADX 15.21
    +DI 21.58
    -DI 17.99
    Chandelier Exit (Long, 3 ATRs) 0.48
    Chandelier Exit (Short, 3 ATRs) 0.61
    Upper Bollinger Bands 0.60
    Lower Bollinger Band 0.45
    Percent B (%b) 0.34
    BandWidth 29.86
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram 0.0037
    Fundamentals Value
    Market Cap 3.85 Million
    Num Shares 7.69 Million
    EPS 0.78
    Price-to-Earnings (P/E) Ratio 0.64
    Price-to-Sales 535.59
    Price-to-Book 33.53
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.55
    Resistance 3 (R3) 0.55 0.54 0.54
    Resistance 2 (R2) 0.54 0.53 0.54 0.54
    Resistance 1 (R1) 0.52 0.52 0.51 0.52 0.54
    Pivot Point 0.50 0.50 0.50 0.50 0.50
    Support 1 (S1) 0.49 0.49 0.48 0.48 0.47
    Support 2 (S2) 0.47 0.48 0.47 0.46
    Support 3 (S3) 0.45 0.47 0.46
    Support 4 (S4) 0.45